Clinical trials
Completed Diabetes Mellitus, Type 2 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6,685 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 31 |
| 2001 | 66 |
| 2002 | 83 |
| 2003 | 108 |
| 2004 | 176 |
| 2005 | 173 |
| 2006 | 239 |
| 2007 | 282 |
| 2008 | 367 |
| 2009 | 403 |
| 2010 | 374 |
| 2011 | 342 |
| 2012 | 329 |
| 2013 | 337 |
| 2014 | 334 |
| 2015 | 319 |
| 2016 | 299 |
| 2017 | 296 |
| 2018 | 281 |
| 2019 | 278 |
| 2020 | 266 |
| 2021 | 302 |
| 2022 | 284 |
| 2023 | 240 |
| 2024 | 223 |
| 2025 | 130 |
| 2026 | 27 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6,685 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 581 |
| AstraZeneca | 280 |
| Eli Lilly and Company | 200 |
| Sanofi | 161 |
| Merck Sharp & Dohme LLC | 154 |
| Boehringer Ingelheim | 122 |
| GlaxoSmithKline | 118 |
| Takeda | 82 |
| Novartis Pharmaceuticals | 61 |
| Pfizer | 60 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 6,685 |
| Diabetes Mellitus | 1,450 |
| Obesity | 584 |
| Insulin Resistance | 401 |
| Diabetes Mellitus, Type 1 | 273 |
| Hypertension | 212 |
| Cardiovascular Diseases | 187 |
| Overweight | 128 |
| Hyperglycemia | 106 |
| Dyslipidemias | 102 |
Trials
Showing 1 to 25 of 6,685. Each trial links to its page on Pharma Observatory.
6,585 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.